Chronic bronchitis Lung Transplant

Jump to navigation Jump to search

Chronic Obstructive Pulmonary Disease Page

Bronchitis Main Page

Chronic bronchitis Microchapters


Patient Information


Historical Perspective




Differentiating Chronic bronchitis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings


Chest X Ray


Echocardiography or Ultrasound


Medical Therapy

Lung Transplant

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic bronchitis Lung Transplant On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Chronic bronchitis Lung Transplant

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic bronchitis Lung Transplant

CDC on Chronic bronchitis Lung Transplant

Chronic bronchitis Lung Transplant in the news

Blogs on Chronic bronchitis Lung Transplant

Directions to Hospitals Treating Chronic bronchitis

Risk calculators and risk factors for Chronic bronchitis Lung Transplant

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]


Lung transplant is primarily done for improvement of symptoms and quality of life. COPD is the leading cause of lung trasplant. Certain criteria have been developed to standardize this approach.

Lung Transplant

Due to the chronic nature of this disease some patients may be qualified for lung transplantation. COPD is considered as the most common indication for lung transplantation.[1]


  • BODE index of 7 to 10 or at least 1 of the following:
  1. History of hospitalization for exacerbation associated with acute hypercapnia (PCO2 > 50 mmHg)
  2. Pulmonary hypertension or cor pulmonale, or both, despite oxygen therapy
  3. FEV1 < 20% and either DlCO < 20% or homogeneous distribution of emphysema[2]


  • Recent malignancy (other than nonmelanoma skin cancer)
  • Active infection with hepatitis B or C virus associated with histologic evidence of significant liver damage
  • Active or recent cigarette smoking, drug abuse, or alcohol abuse
  • Severe psychiatric illness
  • Repeated noncompliance with medical care
  • Absence of a consistent and reliable social support network
  • HIV infection (in some centers AIDS is considered as absolute contraindication)


  1. Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Stehlik J (2014). "The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation". J. Heart Lung Transplant. 33 (10): 1009–24. doi:10.1016/j.healun.2014.08.004. PMID 25242125.
  2. Kreider M, Hadjiliadis D, Kotloff RM (2011). "Candidate selection, timing of listing, and choice of procedure for lung transplantation". Clin. Chest Med. 32 (2): 199–211. doi:10.1016/j.ccm.2011.02.001. PMID 21511083.